Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

计划入组 128 人 · 首次发布于 2005 年 9 月 16 日

Ilaris NIS in Korea

计划入组 25 人 · 首次发布于 2025 年 2 月 20 日

Ilaris (Canakinumab) in the Schnitzler Syndrome

计划入组 1 人 · 首次发布于 2010 年 11 月 22 日

Polaris

HER2 ADC(Araris)

Malaria,Uvax

ACLARIS THERAPEUTICS INC

India

Claris Biotherapeutics, Inc.

United States

Qlaris Bio, Inc.

United States

Baptist Health Achieves 52% Reduction in High-Risk Infusion Errors Through System-Wide Pump Standardization

Federal Circuit Reverses Patent Invalidation for Allergan's IBS-D Drug Viberzi in Landmark Double Patenting Case

Kalaris and AlloVir Complete Merger to Advance Novel Anti-VEGF Therapy for Retinal Diseases